數位糖尿病管理市場報告：2031 年趨勢、預測與競爭分析

全球數位糖尿病管理市場的未來前景光明，在醫院、家庭環境和診斷中心市場都存在機會。預計到 2031 年全球數位糖尿病管理市場規模將達到 344 億美元，2025 年至 2031 年的複合年成長率為 10.8%。該市場的關鍵促進因素是糖尿病盛行率的不斷上升、技術進步以及雲端基礎的糖尿病管理企業解決方案的日益普及。

• Lucintel 預測，由於智慧胰島素幫浦和胰島素貼片在糖尿病管理中自我注射胰島素的應用日益廣泛，穿戴式裝置將在預測期內繼續佔據較大的市場佔有率。
• 根據最終用途，醫院將繼續成為最大的細分市場，這得益於醫院擴大採用數位技術進行遠端患者監護，並且易於獲得先進的數位糖尿病管理工具。
• 根據地區分類，預計北美將在預測期內實現最高成長，這歸因於該地區對聯網糖尿病管理設備的需求不斷增加、糖尿病管理和肥胖應用程式的採用激增以及對自我糖尿病管理的認知不斷增強。

數位糖尿病管理市場的策略性成長機會

技術主導的進步和消費行為的改變正在為數位糖尿病管理市場創造成長機會。關鍵發展重點領域日趨清晰，關鍵應用具有改變的潛力。在本文中，我們提出了五種策略選擇供您考慮。

• 遠端醫療和遠端監控解決方案的擴展：成長機會在於遠端醫療和遠端監控解決方案的擴展。這些設備使醫生能夠進行虛擬訪問，從而增加患者獲得醫療服務的機會。隨著遠端醫療的普及，人們將擴大接受數位工具來支持遠距糖尿病管理和增強患者參與度。
• 穿戴式科技的創新：先進的連續血糖監測儀（CGM）和智慧胰島素筆是穿戴式科技的重大進步，將開啟新的成長機會。與穿戴式裝置協同工作的行動應用程式有可能改善糖尿病治療效果。未來的穿戴式裝置可能具有增強的功能和更高的準確性，從而為患者和醫療保健提供者帶來更好的結果。
• 個人化糖尿病管理系統：基於人工智慧的個人化糖尿病照護系統的發展是真正有可能的。這些解決方案可以根據個人資訊提供有針對性的提案，從而更好地管理疾病。透過解決特定的患者問題，公司可以改善整體管理和健康結果。
• 數位化糖尿病教育計畫的成長：這為數位化糖尿病教育計畫帶來了巨大的成長機會。這些項目可以為患者提供更好地管理病情所需的寶貴資訊、資源和支持。透過整合互動性和引人入勝的內容，數位教育計畫可以提高患者的知識並改善糖尿病照護。

數位糖尿病管理市場的策略性成長機會集中在增強整合、擴大遠端護理以及利用技術提供個人化解決方案。整合平台的發展、穿戴式技術的進步以及數位教育的投資可能會顯著改善糖尿病管理。提供便利、個人化和更​​有效的照護可以再形成這個市場，同時使患者和醫療保健提供者都受益。

數位糖尿病管理市場促進因素與挑戰

數位糖尿病管理市場的成長受到影響其進步的各種因素和挑戰的推動。市場條件受技術進步、經濟因素和監管條件的影響。因此，本文對影響市場的關鍵促進因素和挑戰進行了分析。

數位化糖尿病管理市場受以下因素驅動：

• 技術進步：數位糖尿病管理市場受到各種技術進步的推動，例如改進的 CGM、AI 分析和穿戴式裝置。這些發展將改善血糖監測、資料準確性和個人化護理，從而帶來更好的患者治療效果。
• 遠端醫療的普及率不斷提高：遠端醫療服務的廣泛應用正在擴大糖尿病治療的機會。遠端諮詢和監控選項使患者更容易及時獲得幫助，提高整體控制和依從性。
• 更加關注患者參與：人們越來越關注鼓勵患者自我管理和提高參與度的數位平台。互動式應用程式和線上輔導程序鼓勵患者積極參與糖尿病護理，從而提高對規定治療方法的依從性。

數位化糖尿病管理市場面臨的挑戰包括：

• 資料隱私和安全問題：數位化糖尿病管理的一個關鍵挑戰是保護病患資料的隱私和安全。隨著收集到的健康資訊越來越多，人們開始擔心資料外洩和未授權存取，這可能會影響患者的信任和採用。
• 監管障礙：新數位健康技術的監管要求和核准可能難以獲得。監管障礙可能會減緩創新解決方案的引入並阻礙市場成長。
• 整合和互通性挑戰：將新的數位工具整合到現有的醫療系統中並確保資料互通性面臨挑戰。缺乏標準化和相容性問題可能會阻礙數位化糖尿病護理解決方案的順利採用。

數位糖尿病管理市場的成長受到多種促進因素​​和若干挑戰的影響。技術進步、遠距遠端醫療服務的日益普及以及對病人參與的關注是關鍵促進因素，而資料隱私問題、監管障礙和整合困境則帶來了重大挑戰。為了加速數位化糖尿病管理的進步並改善糖尿病患者的護理，我們必須克服這些瓶頸並利用這些促進因素帶來的機會。

目錄

第1章執行摘要

第 2 章全球數位糖尿病管理市場：市場動態

• 簡介、背景和分類
• 供應鏈
• 產業促進因素與挑戰

第 3 章 市場趨勢與預測分析（2019-2031）

• 宏觀經濟趨勢（2019-2024）與預測（2025-2031）
• 全球數位糖尿病管理市場趨勢（2019-2024 年）與預測（2025-2031 年）
• 全球數位糖尿病管理市場（按產品）
  • 智慧型血糖儀
  • 持續血糖監測系統
  • 智慧胰島素筆
  • 智慧胰島素泵
  • 應用程式
• 全球數位糖尿病管理市場類型
  • 穿戴式裝置
  • 手持裝置
• 全球數位糖尿病管理市場（按最終用途分類）
  • 醫院
  • 居家醫療
  • 診斷中心

第 4 章區域市場趨勢與預測分析（2019-2031 年）

• 全球數位化糖尿病管理市場（按區域）
• 北美數位糖尿病管理市場
• 歐洲數位糖尿病管理市場
• 亞太數位糖尿病管理市場
• 世界其他地區數位糖尿病管理市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球數位糖尿病管理市場成長機會（按產品分類）
  • 全球數位糖尿病管理市場成長機會（按類型）
  • 全球數位糖尿病管理市場成長機會（按最終用途分類）
  • 全球數位糖尿病管理市場各區域成長機會
• 全球數位糖尿病管理市場的新趨勢
• 戰略分析
  • 新產品開發
  • 全球數位化糖尿病管理市場產能擴張
  • 全球數位糖尿病管理市場的企業合併
  • 認證和許可

第7章主要企業簡介

• Abbott Laboratories
• Medtronic
• F. Hoffmann-La Roche
• Bayer
• Lifescan
• Dexcom
• Sanofi
• Insulet Corporation
• Ascensia Diabetes Care Holdings
• B Braun Melsungen

The future of the global digital diabetes management market looks promising with opportunities in the hospital, home setting, and diagnostic center markets. The global digital diabetes management market is expected to reach an estimated $34.4 billion by 2031 with a CAGR of 10.8% from 2025 to 2031. The major drivers for this market are the increasing prevalence of diabetes, technological advancements, and the growing adoption of cloud-based enterprise solutions for diabetes management.

• Lucintel forecasts that, within the type category, wearable devices will remain the larger segment over the forecast period due to the growing adoption of smart insulin pumps and insulin patches for self-insulin delivery for the management of diabetes.
• Within the end use category, hospitals will remain the largest segment due to the increasing adoption of digital technologies for remote patient monitoring and the easy availability of advanced digital diabetes management tools in hospitals.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to the increasing demand for connected diabetes management devices, surging adoption of diabetes management and obesity apps, and growing awareness of self-diabetes management in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Digital Diabetes Management Market

The digital diabetes management market is evolving rapidly through various directions that will shape its future. Numerous innovative solutions and advanced technology integration have led to personalized and efficient approaches to managing diabetes.

• Artificial Intelligence Integration: Digital diabetes management tools are increasingly adopting artificial intelligence (AI). AI algorithms use data from continuous glucose monitors (CGMs) and other sources to offer personalized insights and recommendations. This development enhances prediction, allowing users to make better decisions regarding their diabetes management practices. AI-based tools are improving glucose prediction accuracy, thus enhancing overall disease control and patient outcomes.
• Growth of Wearable Technology: In digital diabetes management, wearable technology is becoming very popular, with examples including smart insulin pens and advanced CGMs. These wearables can monitor glucose levels in real time and deliver insulin automatically, thereby improving convenience and accuracy in managing diabetes. It is now simpler for individuals to monitor their sugar levels with the help of wearable technology, resulting in better patient involvement and improved health outcomes.
• Expansion of Telehealth Services: Diabetes care is being revolutionized by the expansion of telehealth services, which offer remote consultations and support. With digital platforms, patients can connect with healthcare providers without necessarily appearing in their offices, making the management of diabetes mellitus more accessible and convenient. This especially benefits those in remote or underserved areas, who now have better access to specialized care and improved overall diabetes management.
• Enhanced Data Interoperability: This trend is growing because it allows for seamless integration of diabetes management tools into electronic health records (EHRs) and other healthcare systems. It enables better coordination between patients and practitioners, facilitating more comprehensive and efficient care. Sharing enhanced data ensures that all members of the medical team always have the latest patient information, leading to better-informed decisions about treatment that result in improved patient outcomes.

The marketplace has been remodeled by these novel trends within digital diabetes care systems that embrace new technology and inventive solutions, thus improving patient welfare. Diabetes management is being drastically enhanced due to AI integration, wearable technology, telehealth services, data interoperability, and a focus on patient engagement. These trends aim to foster personalized accessibility and efficacy in managing diabetes, thereby significantly improving the health status of diabetes patients and changing the landscape of diabetes treatment.

Recent Developments in the Digital Diabetes Management Market

Recent developments in digital diabetes management have revolutionized diabetes monitoring and treatment. The application of advanced technologies such as wearable devices, mobile apps, and data analytics has led to better patient care and disease control. These improvements have enhanced real-time monitoring capabilities, personalized treatment plans, and increased overall patient involvement.

• Integration of Continuous Glucose Monitoring (CGM) Systems: The integration of continuous glucose monitoring (CGM) systems with mobile applications represents a significant advancement. CGMs provide real-time blood sugar readings that are sent to mobile apps for tracking purposes. With this development, patients can regularly check their blood sugar levels, enabling them to maintain better glycemic control and make more informed decisions about their care regimens. Seamless data sharing between CGMs and apps improves patient engagement and supports early interventions in diabetes.
• Dynamic Progress in Artificial Intelligence (AI) through Diabetic Care: Glucose data is analyzed and trends are predicted using artificial intelligence (AI). AI algorithms analyze CGM data and other sources to generate personalized suggestions or alerts. This technology enables better insulin dosing and more effective diabetes management by predicting glucose fluctuations before they occur. The overall treatment outcomes from AI in predicting and managing diabetes are improving, leading to more individualized care.
• Expansion of Telehealth Services: The expansion of telehealth services has changed how diabetes is managed by providing remote consultations and support. Patients can now consult medical practitioners without having to travel long distances, especially those who live in rural areas with limited access to health services. Telehealth platforms ensure continuous monitoring and timely check-ins, ensuring that patients receive the right support when it is most needed. This development improves accessibility and convenience for individuals managing diabetes.
• Increased Focus on Patient Engagement Platforms: Patient engagement platforms are becoming increasingly popular. Consequently, diabetes patients are being educated and empowered through interactive apps and digital coaching programs. These platforms have features that help monitor progress, set goals, and motivate users. As a result, patients are now adhering to treatment regimens, thereby enhancing their overall health.

The digital diabetes management market has recently undergone numerous changes that have made it more accurate and patient-friendly. Diabetes is monitored and managed differently today through combined glucose monitoring devices, AI-powered analytics, remote healthcare services, patient engagement systems, and smart insulin pens. Consequently, diabetic patients now have improved access to care, including real-time data provision, personalized recommendations, and better outcomes.

Strategic Growth Opportunities for Digital Diabetes Management Market

Technology-driven advancements and transforming consumer behavior have created opportunities for growth in the digital diabetes management market. Focused areas for development are becoming apparent, with key applications offering a potentially transformative experience. This article presents five strategic options to consider.

• Expansion of Telemedicine and Remote Monitoring Solutions: The opportunity for growth lies in expanding telehealth and remote monitoring solutions. These devices enable physicians to conduct virtual visits, thereby increasing access to healthcare services for patients. The increased acceptance of digital tools that support remote diabetes management and enhance patient involvement can be observed as more distance care is utilized.
• Innovation in Wearable Technology: Advanced continuous glucose monitors (CGMs) and smart insulin pens represent significant advancements in wearable technology that present new growth opportunities. Mobile applications that connect with wearable devices have the potential to improve diabetes treatment outcomes. Future wearables could include enhanced functionalities and increased accuracy, resulting in better outcomes for patients and providers.
• Personalized Diabetes Management Systems: Developing AI-based personalized systems for diabetes care is a viable possibility. Such solutions can offer accurate suggestions based on individual information, leading to better disease control. By addressing specific patient issues, companies can enhance overall management and health outcomes.
• Growth of Digital Diabetes Education Programs: This presents a significant growth opportunity for digital diabetes education programs. These programs can provide patients with valuable information, resources, and support necessary for better managing their condition. By incorporating interactive and engaging content, patient knowledge in digital education programs can be enhanced, leading to improved diabetes care.

Strategic growth opportunities in the digital diabetes management market focus on enhancing integration, expanding remote care, and leveraging technology for personalized solutions. The development of integrated platforms, advancements in wearable technology, and investments in digital education could lead to substantial improvements in diabetes management. More effective care offerings that are accessible and personalized can reshape this market while benefiting both patients and healthcare providers.

Digital Diabetes Management Market Driver and Challenges

The growth of the digital diabetes management market is influenced by various factors and challenges that impact its progress. The market landscape is shaped by technological advancements, economic factors, and regulatory considerations. Thus, this paper presents an analysis of major drivers and challenges affecting the market.

The factors driving the digital diabetes management market include:

• Technological Advancements: The digital diabetes management market is being driven by a range of technological advancements, including improved CGMs, AI analytics, and wearable devices. These developments boost glucose monitoring, data precision, and individualized care, thereby leading to better patient outcomes.
• Increased Adoption of Telehealth: The increasing uptake of telehealth services is widening access to diabetes treatment. Remote consultation and monitoring options are making it easier for patients to receive timely assistance, enhancing overall control and adherence.
• Growing Focus on Patient Engagement: There is an increasing focus on digital platforms that encourage patient self-management and improve engagement. Interactive applications and online coaching programs help individuals participate more actively in their diabetes care, resulting in greater compliance with prescribed treatment regimens.

Challenges in the digital diabetes management market include:

• Data Privacy and Security Concerns: A significant challenge in digital diabetes management is protecting the privacy and security of patient data. As more health information is collected, there are concerns about data breaches and unauthorized access, which can impact patient trust and adoption.
• Regulatory Hurdles: Navigating regulatory requirements and obtaining approvals for new digital health technologies can be difficult. Regulatory barriers may delay the introduction of innovative solutions and hinder market growth.
• Integration and Interoperability Issues: Challenges arise when integrating new digital tools into existing healthcare systems and ensuring data interoperability. Lack of standardization and compatibility issues may prevent the smooth use of digital diabetes care solutions.

Various drivers shape the growth of the digital diabetes management market, along with several challenges. Technological advancements, increased adoption of telehealth services, and a focus on patient engagement are its main drivers, while concerns over data privacy, regulatory hurdles, and integration dilemmas pose significant challenges. To foster progress in digital diabetes management and improve care for diabetic patients, we must overcome these bottlenecks and capitalize on the opportunities presented by these drivers.

List of Digital Diabetes Management Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies digital diabetes management companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the digital diabetes management companies profiled in this report include-

• Abbott Laboratories
• Medtronic
• F. Hoffmann-La Roche
• Bayer
• Lifescan
• Dexcom
• Sanofi
• Insulet Corporation
• Ascensia Diabetes Care Holdings
• B Braun Melsungen

Digital Diabetes Management by Segment

The study includes a forecast for the global digital diabetes management market by product, type, end use, and region

Digital Diabetes Management Market by Product [Analysis by Value from 2019 to 2031]:

• Smart Glucose Meter
• Continuous Blood Glucose Monitoring System
• Smart Insulin Pens
• Smart Insulin Pumps
• Apps

Digital Diabetes Management Market by Type [Analysis by Value from 2019 to 2031]:

• Wearable Devices
• Handheld Devices

Digital Diabetes Management Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Home settings
• Diagnostic Centers

Digital Diabetes Management Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Digital Diabetes Management Market

Digital diabetes management has been experiencing significant recent advancements that have greatly influenced the approach to diabetes care globally. Patient monitoring, engagement, and treatment personalization are being enhanced by advanced technological integrations such as wearable devices, mobile apps, and artificial intelligence (AI). These innovations address the increasing need for efficient and user-friendly solutions for diabetes management, offering real-time data and insights to improve patient outcomes.

• United States: In the United States, there has been noticeable uptake of high-tech digital diabetes management platforms. For example, continuous glucose monitors (CGMs) can now be integrated with smartphone applications, enabling real-time glucose tracking and management. Moreover, analytics based on AI are improving predictive capabilities, facilitating personalized therapies. Teleservices, such as telehealth and digital diabetes coaching, have also grown, reinforcing proper disease control and improving patient relationships while increasing access to care.
• China: The expansion of mobile health (mHealth) applications and telemedicine is driving rapid growth in digital diabetes management in China. Local tech companies are designing sophisticated platforms that merge CGM data with health management apps, providing users with comprehensive diabetes control tools. Government initiatives have been implemented to promote the integration of digital health solutions into mainstream care delivery systems, enhancing access and encouraging widespread utilization of diabetes management technologies in urban and rural areas.
• Germany: Smart insulin pens and advanced CGMs have revolutionized digital diabetes management in Germany. The use of these devices has improved glucose monitoring accuracy and insulin delivery. Moreover, Germany emphasizes data interoperability to enable easy integration between EHRs and diabetes management tools. Consequently, this connection enhances coordination between medical practitioners and their clients, leading to better treatment outcomes for both patients who comply with prescribed medications and the physicians themselves.
• India: India has seen the expansion of digital diabetes management through affordable mobile applications and wearable technologies. To address the high prevalence of diabetes in India, these tools provide simple-to-use glucose monitoring and management solutions. In particular, the growth of telemedicine platforms is facilitating access to diabetes care in underserved and remote areas. Efforts are underway to boost digital literacy and integrate these innovations into conventional healthcare delivery systems.
• Japan: Through highly accurate CGMs and automated insulin delivery systems, Japan is advancing in digital diabetes management. The goal is to integrate these systems with national health databases to improve patient tracking and intervention efficiency. Moreover, Japan is exploring AI-driven predictive analytics and personalized diabetes interventions that will enhance clinical performance among patients and streamline healthcare services. Furthermore, more patient education avenues, such as online platforms, are now available for individuals managing this disease.

Features of the Global Digital Diabetes Management Market

Market Size Estimates: Digital diabetes management market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Digital diabetes management market size by product, type, end use, and region in terms of value ($B).

Regional Analysis: Digital diabetes management market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, types, end uses, and regions for the digital diabetes management market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the digital diabetes management market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the digital diabetes management market by product (smart glucose meter, continuous blood glucose monitoring system, smart insulin pens, smart insulin pumps, and apps), type (wearable devices and handheld devices), end use (hospitals, home settings, and diagnostic centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Digital Diabetes Management Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Digital Diabetes Management Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Digital Diabetes Management Market by Product
  • 3.3.1: Smart Glucose Meter
  • 3.3.2: Continuous Blood Glucose Monitoring System
  • 3.3.3: Smart Insulin Pens
  • 3.3.4: Smart Insulin Pumps
  • 3.3.5: Apps
• 3.4: Global Digital Diabetes Management Market by Type
  • 3.4.1: Wearable Devices
  • 3.4.2: Handheld Devices
• 3.5: Global Digital Diabetes Management Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Home settings
  • 3.5.3: Diagnostic Centers

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Digital Diabetes Management Market by Region
• 4.2: North American Digital Diabetes Management Market
  • 4.2.1: North American Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
  • 4.2.2: North American Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
• 4.3: European Digital Diabetes Management Market
  • 4.3.1: European Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
  • 4.3.2: European Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
• 4.4: APAC Digital Diabetes Management Market
  • 4.4.1: APAC Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
  • 4.4.2: APAC Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
• 4.5: ROW Digital Diabetes Management Market
  • 4.5.1: ROW Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
  • 4.5.2: ROW Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Digital Diabetes Management Market by Product
  • 6.1.2: Growth Opportunities for the Global Digital Diabetes Management Market by Type
  • 6.1.3: Growth Opportunities for the Global Digital Diabetes Management Market by End Use
  • 6.1.4: Growth Opportunities for the Global Digital Diabetes Management Market by Region
• 6.2: Emerging Trends in the Global Digital Diabetes Management Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Digital Diabetes Management Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Digital Diabetes Management Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Laboratories
• 7.2: Medtronic
• 7.3: F. Hoffmann-La Roche
• 7.4: Bayer
• 7.5: Lifescan
• 7.6: Dexcom
• 7.7: Sanofi
• 7.8: Insulet Corporation
• 7.9: Ascensia Diabetes Care Holdings
• 7.10: B Braun Melsungen